Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector

Springer Seminars in Immunopathology

Volumn 28, Issue 3, 2006, Pages 239-253

  Clarke, David K ^a   Cooper, David ^a   Egan, Michael A ^a   Hendry, R Michael ^a   Parks, Christopher L ^a   Udem, Stephen A ^a,b  

^a WYETH RESEARCH   (United States)

^b INTERNATIONAL AIDS VACCINE INITIATIVE   (United States)

Author keywords

AIDS; Immunogenicity; Neurovirulence; Safety; VSV

Indexed keywords

GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOLOGICAL ADJUVANT; IMMUNOMODULATING AGENT; INFLUENZA VACCINE; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; ARTICLE; CELL GROWTH; CELL LINE; CELLULAR IMMUNITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOGENICITY; NONHUMAN; PATHOGENESIS; PRIMATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROPREVALENCE; SIMIAN IMMUNODEFICIENCY VIRUS; UPREGULATION; VACCINE PRODUCTION; VESICULAR STOMATITIS VIRUS; VIRAL GENE THERAPY; VIRUS GENE; VIRUS MORPHOLOGY; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS VECTOR;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; GENETIC VECTORS; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC FACTORS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VACCINES, SYNTHETIC; VESICULAR STOMATITIS-INDIANA VIRUS;

EID: 33751099557     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00281-006-0042-3     Document Type: Article

References (118)

1. Abraham G, Banerjee AK (1976) Sequential transcription of the genes of vesicular stomatitis virus. Proc Natl Acad Sci USA 73:1504
2. Ahmed M, McKenzie MO, Puckett S et al (2003) Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis. J Virol 77:4646
3. Arnheiter H, Davis NL, Wertz G et al (1985) Role of the nucleocapsid protein in regulating vesicular stomatitis virus RNA synthesis. Cell 41:259
4. Ball LA, White CN (1976) Order of transcription of genes of vesicular stomatitis virus. Proc Natl Acad Sci USA 73:442
5. Ball LA, Pringle CR, Flanagan B et al (1999) Phenotypic consequences of rearranging the P, M, and G genes of vesicular stomatitis virus. J Virol 73:4705
6. Bergold GH, Suarez OM, Munz K (1968) Multiplication in and transmission by Aedes aegypti of vesicular stomatitis virus. J Invertebr Pathol 11:406
7. Bhatt PN, Rodrigues FM (1967) Chandipura: a new Arbovirus isolated in India from patients with febrile illness. Indian J Med Res 55:1295
8. Black BL, Lyles DS (1992) Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo. J Virol 66:4058
9. Blumberg BM, Leppert M, Kolakofsky D (1981) Interaction of VSV leader RNA and nucleocapsid protein may control VSV genome replication. Cell 23:837
10. Blumberg BM, Giorgi C, Kolakofsky D (1983) N protein of vesicular stomatitis virus selectively encapsidates leader RNA in vitro. Cell 32:559
11. Buonocore L, Blight KJ, Rice CM et al (2002) Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins. J Virol 76:6865
12. Calisher CH, Monath TP, Sabattini MS et al (1987) A newly recognized vesiculovirus, Calchaqui virus, and subtypes of Melao and Maguari viruses from Argentina, with serologic evidence for infections of humans and horses. Am J Trop Med Hyg 36:114
13. Carroll AR, Wagner RR (1979) Role of the membrane (M) protein in endogenous inhibition of in vitro transcription by vesicular stomatitis virus. J Virol 29:134
14. Casimiro DR, Chen L, Fu TM et al (2003) Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene. J Virol 77:6305
15. Clinton GM, Little SP, Hagen FS et al (1978) The matrix (M) protein of vesicular stomatitis virus regulates transcription. Cell 15:1455
16. Das T, Pattnaik AK, Takacs AM et al (1997) Basic amino acid residues at the carboxy-terminal eleven amino acid region of the phosphoprotein (P) are required for transcription but not for replication of vesicular stomatitis virus genome RNA. Virology 238:103
17. Dhanda V, Rodrigues FM, Ghosh SN (1970) Isolation of Chandipura virus from sandflies in Aurangabad. Indian J Med Res 58:179
18. Domingo E, Holland JJ (1997) RNA virus mutations and fitness for survival. Annu Rev Microbiol 51:151
19. Egan MA, Chong SY, Rose NF et al (2004) Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes. AIDS Res Hum Retroviruses 20:989
20. Egan MA, Chong SY, Megati S et al (2005) Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus. AIDS Res Hum Retroviruses 21:629
21. Emerson SU, Yu Y (1975) Both NS and L proteins are required for in vitro RNA synthesis by vesicular stomatitis virus. J Virol 15:1348
22. Ezelle HJ, Markovic D, Barber GN (2002) Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector. J Virol 76:12325
23. Faria PA, Chakraborty P, Levay A et al (2005) VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway. Mol Cell 17:93
24. Fields BN, Hawkins K (1967) Human infection with the virus of vesicular stomatitis during an epizootic. New Engl J Med 277:989
25. Finke S, Conzelmann KK (2005) Recombinant rhabdoviruses: vectors for vaccine development and gene therapy. Curr Top Microbiol Immunol 292:165
26. Flamand A (1970) Genetic study of vesicular stomatitis virus: classification of spontaneous thermosensitive mutants into complementation groups (in French). J Gen Virol 8:187
27. Flanagan EB, Zamparo JM, Ball LA et al (2001) Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development. J Virol 75:6107
28. Flanagan EB, Schoeb TR, Wertz GW (2003) Vesicular stomatitis viruses with rearranged genomes have altered invasiveness and neuropathogenesis in mice. J Virol 77:5740
29. Frank AH, Appleby A, Seibold HR (1945) Experimental intracerebral infection of horses, cattle, and sheep with the virus of vesicular stomatitis. Am J Vet Res 28
30. Fredericksen BL, Whitt MA (1998) Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness. Virology 240:349
31. Fukushi S, Mizutani T, Saijo M et al (2005) Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. J Gen Virol 86:2269
32. Garbutt M, Liebscher R, Wahl-Jensen V et al (2004) Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J Virol 78:5458
33. Geisbert TW, Jones S, Fritz EA et al (2005) Development of a new vaccine for the prevention of Lassa fever. PLoS Med 2:e183
34. Haglund K, Forman J, Krausslich HG et al (2000) Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope. Virology 268:112
35. Haglund K, Leiner I, Kerksiek K et al (2002) Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins. J Virol 76:7506
36. Harty RN, Paragas J, Sudol M et al (1999) A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding. J Virol 73:2921
37. Holland J, Spindler K, Horodyski F et al (1982) Rapid evolution of RNA genomes. Science 215:1577
38. Huneycutt BS, Plakhov IV, Shusterman Z et al (1994) Distribution of vesicular stomatitis virus proteins in the brains of BALB/c mice following intranasal inoculation: an immunohistochemical analysis. Brain Res 635:81
39. Iverson LE, Rose JK (1981) Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription. Cell 23:477
40. Jacobs BL, Penhoet EE (1982) Assembly of vesicular stomatitis virus: distribution of the glycoprotein on the surface of infected cells. J Virol 44:1047
41. Jayakar HR, Whitt MA (2002) Identification of two additional translation products from the matrix (M) gene that contribute to vesicular stomatitis virus cytopathology. J Virol 76:8011
42. Johnson KM, Vogel JE, Peralta PH (1966) Clinical and serological response to laboratory-acquired human infection by Indiana type vesicular stomatitis virus (VSV). Am J Trop Med Hyg 15:244
43. Johnson JE, Schnell MJ, Buonocore L et al (1997) Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins. J Virol 71:5060
44. Jones SM, Feldmann H, Stroher U et al (2005) Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med 11:786
45. Jonkers AH (1967) The epizootiology of the vesicular stomatitis viruses: a reappraisal. Am J Epidemiol 86:286
46. Jonkers AH, Shope RE, Aitken TH et al (1964) Cocal virus, a new agent in Trinidad related to vesicular stomatitis virus, type Indiana. Am J Vet Res 25:236
47. Jonkers AH, Spence L, Aitken TH (1965) Cocal virus epizootiology in Bush Bush Forest and the Nariva Swamp, Trinidad, W.I.: further studies. Am J Vet Res 26:758
48. Justice PA, Sun W, Li Y et al (1995) Membrane vesiculation function and exocytosis of wild-type and mutant matrix proteins of vesicular stomatitis virus. J Virol 69:3156
49. Kahn JS, Schnell MJ, Buonocore L et al (1999) Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion. Virology 254:81
50. Kahn JS, Roberts A, Weibel C et al (2001) Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge. J Virol 75:11079
51. Kapadia SU, Rose JK, Lamirande E et al (2005) Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine. Virology 340:174
52. Klas SD, Robison CS, Whitt MA et al (2002) Adjuvanticity of an IL-12 fusion protein expressed by recombinant deltaG-vesicular stomatitis virus. Cell Immunol 218:59
53. Klas SD, Lavine CL, Whitt MA et al (2006) IL-12-assisted immunization against listeria monocytogenes using replication-restricted VSV-based vectors. Vaccine 24:1451
54. Kopecky SA, Lyles DS (2003) The cell-rounding activity of the vesicular stomatitis virus matrix protein is due to the induction of cell death. J Virol 77:5524
55. Kreis TE, Lodish HF (1986) Oligomerization is essential for transport of vesicular stomatitis viral glycoprotein to the cell surface. Cell 46:929
56. Kretzschmar E, Buonocore L, Schnell MJ et al (1997) High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses. J Virol 71:5982
57. Lawson ND, Stillman EA, Whitt MA et al (1995) Recombinant vesicular stomatitis viruses from DNA. Proc Natl Acad Sci USA 92:4477
58. Lee BH, Yoshimatsu K, Araki K et al (2006) A pseudotype vesicular stomatitis virus containing Hantaan virus envelope glycoproteins G1 and G2 as an alternative to hantavirus vaccine in mice. Vaccine 24:2928
59. Leppert M, Rittenhouse L, Perrault J et al (1979) Plus and minus strand leader RNAs in negative strand virus-infected cells. Cell 18:735
60. Levenbook IS, Pelleu LJ, Elisberg BL (1987) The monkey safety test for neurovirulence of yellow fever vaccines: the utility of quantitative clinical evaluation and histological examination. J Biol Stand 15:305
61. Lorin C, Mollet L, Delebecque F et al (2004) A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV. J Virol 78:146
62. Lund JM, Alexopoulou L, Sato A et al (2004) Recognition of single-stranded RNA viruses by Toll-like receptor 7 (see comment). Proc Natl Acad Sci USA 101:5598
63. Maher JA, DeStefano J (2004) The ferret: an animal model to study influenza virus. Lab Anim (NY) 33:50
64. Maines TR, Lu XH, Erb SM et al (2005) Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol 79:11788
65. Maximova O, Dragunsky E, Taffs R et al (1996) Monkey neurovirulence test for live mumps vaccine. Biologicals 24:223
66. Metsikko K, Simons K (1986) The budding mechanism of spikeless vesicular stomatitis virus particles. EMBO J 5:1913
67. Miyoshi K, Harter DH, Hsu KC (1971) Neuropathological and immunofluorescence studies of experimental vesicular stomatitis virus encephalitis in mice. J Neuropathol Exp Neurol 30:266
68. Nathanson N, Horn SD (1992) Neurovirulence tests of type 3 oral poliovirus vaccine manufactured by Lederle Laboratories, 1964-1988. Vaccine 10:469
69. Natuk RJ, Cooper D, Guo M et al (2006) Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge. J Virol 80:4447
70. Olitsky PK, Cox HR, Syverton JT (1934) Comparative studies on the viruses of vesicular stomatitis and equine encephalomyelitis. J Exp Med 59:159
71. Owens RJ, Rose JK (1993) Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus. J Virol 67:360
72. Palin A, Chattopadhyay A, Park S et al (2006) An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge. Vaccine (in press). DOI 10.1016/j.vaccine.2006.08.010
73. Pattnaik AK, Hwang L, Li T et al (1997) Phosphorylation within the amino-terminal acidic domain I of the phosphoprotein of vesicular stomatitis virus is required for transcription but not for replication. J Virol 71:8167
74. Patton JT, Davis NL, Wertz GW (1983) Cell-free synthesis and assembly of vesicular stomatitis virus nucleocapsids. J Virol 45:155
75. Plakhov IV, Arlund EE, Aoki C et al (1995) The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system. Virology 209:257
76. Pringle CR (1970) Genetic characteristics of conditional lethal mutants of vesicular stomatitis virus induced by 5-fluorouracil, 5-azacytidine, and ethyl methane sulfonate. J Virol 5:559
77. Pringle CR (1982) The genetics of vesiculoviruses. Arch Virol 72:1
78. Ramsburg E, Rose NF, Marx PA et al (2004) Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol. J Virol 78:3930
79. Ramsburg E, Publicover J, Buonocore L et al (2005) A vesicular stomatitis virus recombinant expressing granulocyte-macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animals. J Virol 79:15043
80. Rao TR, Singh KR, Dhanda V et al (1967) Experimental transmission of Chandipura virus by mosquitoes. Indian J Med Res 55:1306
81. Reiss CS, Plakhov IV, Komatsu T (1998) Viral replication in olfactory receptor neurons and entry into the olfactory bulb and brain. Ann N Y Acad Sci 30:752
82. Reuter JD, Vivas-Gonzalez BE, Gomez D et al (2002) Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease. J Virol 76:8900
83. Riedel H, Kondor-Koch C, Garoff H (1984) Cell surface expression of fusogenic vesicular stomatitis virus G protein from cloned cDNA. EMBO J 3:1477
84. Roberts A, Kretzschmar E, Perkins AS et al (1998) Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J Virol 72:4704
85. Roberts A, Buonocore L, Price R et al (1999) Attenuated vesicular stomatitis viruses as vaccine vectors. J Virol 73:3723
86. Robison CS, Whitt MA (2000) The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly. J Virol 74:2239
87. Rose JK, Whitt MA (2001) Rhabdoviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology, 4th edn. Lippincott Williams and Wilkins, Philadelphia, PA, p 1223
88. Rose NF, Roberts A, Buonocore L et al (2000) Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1. J Virol 74:10903
89. Rose NF, Marx PA, Luckay A et al (2001) An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell 106:539
90. Rowe T, Cho DS, Bright RA et al (2003) Neurological manifestations of avian influenza viruses in mammals. Avian Dis 47:1122
91. Rubin SA, Snoy PJ, Wright KE et al (1999) The mumps virus neurovirulence safety test in rhesus monkeys: a comparison of mumps virus strains. J Infect Dis 180:521
92. Sabin AB, Olitsky PK (1937) Influence of host factors on neuroinvasiveness of vesicular stomatitis virus: I. Effect of age on the invasion of the brain by virus instilled in the nose. J Exp Med 66:15
93. Scheiblauer H, Kendal AP, Rott R (1995) Pathogenicity of influenza A/Seal/Mass/1/80 virus mutants for mammalian species. Arch Virol 140:341
94. Schlereth B, Rose JK, Buonocore L et al (2000) Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies. J Virol 74:4652
95. Schnell MJ, Mebatsion T, Conzelmann KK (1994) Infectious rabies viruses from cloned cDNA. EMBO J 13:4195
96. Schnell MJ, Buonocore L, Whitt MA et al (1996) The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. J Virol 70:2318
97. Schnell MJ, Johnson JE, Buonocore L et al (1997) Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell 90:849
98. Schnell MJ, Buonocore L, Boritz E et al (1998) Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus. EMBO J 17:1289
99. Sharova OK, Rozina EE, Shteinberg LS et al (1979) Morphological characterisitcs of the pathological process in the central nervous system of monkeys infected with variants of measles virus strain L-16. Acta Virol 23:393
100. Shinya K, Hatta M, Yamada S et al (2005) Characterization of a human H5N1 influenza A virus isolated in 2003. J Virol 79:9926
101. tenOever BR, Sharma S, Zou Wet al (2004) Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity. J Virol 78:10636
102. Tesh RB, Johnson KM (1975) Vesicular stomatitis. In: Hubbert WT, McCulloch WF, Schnurrenberger PR (eds) Diseases transmitted from animals to man, 6th edn. C. C. Thomas, Springfield, IL, p 897
103. Tesh RB, Modi GB (1983) Growth and transovarial transmission of Chandipura virus (Rhabdoviridae: Vesiculovirus) in Phlebotomus papatasi. Am J Trop Med Hyg 32:621
104. Tesh RB, Peralta PH, Johnson KM (1970) Ecologic studies of vesicular stomatitis virus. II. Results of experimental infection in Panamanian wild animals. Am J Epidemiol 91:216
105. Tesh RB, Chaniotis BN, Johnson KM (1971) Vesicular stomatitis virus, Indiana serotype: multiplication in and transmission by experimentally infected phlebotomine sandflies (Lutzomyia trapidoi). Am J Epidemiol 93:491
106. Tesh RB, Chaniotis BN, Johnson KM (1972) Vesicular stomatitis virus (Indiana serotype): transovarial transmission by phlebotomine sandflies. Science 175:1477
107. Tesh R, Saidi S, Javadian E et al (1977) Isfahan virus, a new vesiculovirus infecting humans, gerbils, and sandflies in Iran. Am J Trop Med Hyg 26:299
108. Tesh RB, Travassos Da Rosa AP, Travassos Da Rosa JS (1983) Antigenic relationship among rhabdoviruses infecting terrestrial vertebrates. J Gen Virol 64(Pt 1):169
109. Tesh RB, Boshell J, Modi GB et al (1987) Natural infection of humans, animals, and phlebotomine sand flies with the Alagoas serotype of vesicular stomatitis virus in Colombia. Am J Trop Med Hyg 36:653
110. Travassos da Rosa AP, Tesh RB, Travassos da Rosa JF et al (1984) Carajas and Maraba viruses, two new vesiculoviruses isolated from phlebotomine sand flies in Brazil. Am J Trop Med Hyg 33:999
111. van den Pol AN, Dalton KP, Rose JK (2002) Relative neurotropism of a recombinant rhabdovirus expressing a green fluorescent envelope glycoprotein. J Virol 76:1309
112. Villarreal LP, Breindl M, Holland JJ (1976) Determination of molar ratios of vesicular stomatitis virus induced RNA species in BHK21 cells. Biochemistry 15:1663
113. Wertz GW (1983) Replication of vesicular stomatitis virus defective interfering particle RNA in vitro: transition from synthesis of defective interfering leader RNA to synthesis of full-length defective interfering RNA. J Virol 46:513
114. Wertz GW, Perepelitsa VP, Ball LA (1998) Gene rearrangement attenuates expression and lethality of a nonsegmented negative strand RNA virus. Proc Natl Acad Sci USA 95:3501
115. Whelan SP, Wertz GW (1999) Regulation of RNA synthesis by the genomic termini of vesicular stomatitis virus: identification of distinct sequences essential for transcription but not replication. J Virol 73:297
116. Whelan SP, Ball LA, Barr JN et al (1995) Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc Natl Acad Sci USA 92:8388
117. Xing Z, Lichty BD (2006) Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization. Tuberculosis (Edinb) 86:211
118. Zagouras P, Rose JK (1993) Dynamic equilibrium between vesicular stomatitis virus glycoprotein monomers and trimers in the Golgi and at the cell surface. J Virol 67:7533